stoxline Quote Chart Rank Option Currency Glossary
  
iRhythm Technologies, Inc. (IRTC)
100.435  4.685 (4.89%)    06-18 10:42
Open: 95.26
High: 101.295
Volume: 77,873
  
Pre. Close: 95.75
Low: 93.54
Market Cap: 3,124(M)
Technical analysis
2024-06-18 10:20:07 AM
Short term     
Mid term     
Targets 6-month :  118.72 1-year :  138.67
Resists First :  101.65 Second :  118.72
Pivot price 91.77
Supports First :  89.87 Second :  82.59
MAs MA(5) :  94.49 MA(20) :  91.17
MA(100) :  106.93 MA(250) :  100.65
MACD MACD :  -1.1 Signal :  -2.5
%K %D K(14,3) :  83.4 D(3) :  75.1
RSI RSI(14): 54.2
52-week High :  124.11 Low :  70.23
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ IRTC ] has closed below upper band by 18.8%. Bollinger Bands are 4.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 96.26 - 96.65 96.65 - 97.05
Low: 91.52 - 91.91 91.91 - 92.32
Close: 95.09 - 95.79 95.79 - 96.51
Company Description

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Headline News

Mon, 17 Jun 2024
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing ... - StockTitan

Thu, 13 Jun 2024
Investigation Alert Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson ... - GlobeNewswire

Wed, 12 Jun 2024
First Light Asset Management LLC Acquires 64,024 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat

Sun, 09 Jun 2024
Possible Bearish Signals With iRhythm Technologies Insiders Disposing Stock - Simply Wall St

Fri, 07 Jun 2024
Marc W. Rosenbaum Sells 510 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) Stock - Defense World

Fri, 07 Jun 2024
Sumi Shrishrimal Sells 1131 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) Stock - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 31 (M)
Shares Float 31 (M)
Held by Insiders 0.8 (%)
Held by Institutions 113 (%)
Shares Short 3,060 (K)
Shares Short P.Month 2,810 (K)
Stock Financials
EPS -4.22
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.9
Profit Margin -25.4 %
Operating Margin -29 %
Return on Assets (ttm) -9.1 %
Return on Equity (ttm) -83.3 %
Qtrly Rev. Growth 18.3 %
Gross Profit (p.s.) 0
Sales Per Share 16.5
EBITDA (p.s.) -2.97
Qtrly Earnings Growth 0 %
Operating Cash Flow -71 (M)
Levered Free Cash Flow -29 (M)
Stock Valuations
PE Ratio -23.01
PEG Ratio 0
Price to Book value 33.47
Price to Sales 5.88
Price to Cash Flow -42.31
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android